Children's Cancer Group, China

This study tests a modified chemotherapy regimen for Chinese children and adolescents newly diagnosed with lymphoblastic lymphoma. The goal is to improve survival rates compared to previous treatments. About 150 participants will receive the adjusted therapy, and researchers will…

This study tests whether a treatment plan that works well in the US and Europe can also help Chinese children and teens with newly diagnosed Hodgkin lymphoma. About 200 participants aged 1 to 18 will receive a modified version of the COG (Children's Oncology Group) protocol. The …

This study tests a modified chemotherapy regimen (ALCL99) in 172 Chinese children and teens with high-risk anaplastic large cell lymphoma. The goal is to see if the new plan improves 3-year survival without the cancer coming back, while also tracking side effects. Participants re…

This study tests whether adding 4 injections of rituximab to stronger chemotherapy can help children and teens with mature B-cell non-Hodgkin lymphoma or B-cell acute leukemia live longer without the cancer coming back. About 200 participants in China will receive the new regimen…